Artificial intelligence (AI) will play a serious function in the way forward for healthcare, based on Dr Ngiam.
“Being capable of help scientific choices based mostly on extremely correct predictions of sufferers’ outcomes could be a sport changer. If that is completed at inhabitants scale, I believe that may change the way in which we apply medication as we all know it,” he says.
Over the years, Dr Ngiam has been awarded quite a few awards for his work in analysis and schooling, together with the ExxonMobil-NUS analysis fellowship for clinicians in 2007.
Innovation in healthcare
At NUHS, he’s accountable for overseeing know-how deployment in the western healthcare cluster and serves as chief advisor to the NUHS Centre for Innovation in Healthcare.
“Being capable of launch a few of these platforms and realise the potential of the AI instruments in scientific apply might be one of many key highlights of my profession,” Dr Ngiam says. “Specifically in the final 4 years, we have managed to construct, launch and function Discovery AI, which is a platform that permits our clinicians and researchers to make use of the info we have now to develop AI instruments.”
“If you take a look at the world of healthcare AI, there are lots of publications and papers however only a few precise scientific use circumstances,” Dr Ngiam explains. “What we wish to do in the subsequent few years is deploy and scale AI instruments that we have been doing a lot analysis on in scientific apply. And to that finish, we have now constructed a platform referred to as Endeavour AI, which we’ll be launching quickly.”
One widespread concern is that AI might erode the connection between sufferers and clinicians, however Dr Ngiam refutes this.
“These AI instruments don’t change the clinicians in any approach. They help the clinicians in performing the form of repetitive menial duties that must be completed by machines,” he says. “Ethical and authorized issues in the way in which docs use AI determination help must be addressed by means of rigorous validation of AI instruments, in addition to acceptable coaching of clinicians in their use.”
Working collectively
Dr Ngiam can be affiliate professor, division of surgical procedure at Yong Loo Lin college of drugs, the place he researches AI purposes in healthcare and endocrine and metabolic surgical procedure.
He is a robust advocate of interdisciplinary collaboration between the faculties of drugs, engineering and pc science.
“Clinicians haven’t got the technical potential to construct an AI software floor up from scratch by themselves, so usually we have to collaborate with pc science or knowledge scientists,” he says. “This is a primary instance of how interdisciplinary collaboration may end up in a product that’s relevant to the healthcare system, in addition to generate new data in pc science and knowledge science.”
Dr Ngiam is talking on the HIMSS21 APAC Conference through the keynote session, Getting Personal with Emerging Tech. This totally digital occasion will happen on 18 & 19 October and is free for all healthcare suppliers. Register right here.
A passion for AI in healthcare
